Products
Products

Portfolio

Committed to better health for individuals, Takeda Pharmaceuticals North America, Inc. (TPNA) develops and markets innovative pharmaceutical treatments.

In addition to the success of our on-the-market products, Takeda invests in an active R&D pipeline in an effort to bring new treatments to patients in need.

Click here for more R&D pipeline information.

The following prescription drugs are listed for physicians and healthcare professionals.

Click on the product links for more detailed information.

Brand Name
Click name for product and important safety information.		 Generic Name Prescribing Information
ACTOS pioglitazone HCl Prescribing Information including black box warning
ACTOplus met pioglitazone HCl and metformin HCl Prescribing Information including black box warning
ACTOplus met XR pioglitazone HCl and metformin HCl
(extended release)		 Prescribing Information including black box warning and medication guide
AMITIZA lubiprostone Prescribing Information
Duetact pioglitazone HCl and glimepiride Prescribing Information including black box warning
KAPIDEX dexlansoprazole Prescribing Information
PREVACID lansoprazole Prescribing Information
ROZEREM ramelteon Prescribing Information, including medication guide
ULORIC febuxostat Prescribing Information

ACTOS®, ACTOplus met®, ACTOplus met® XR, duetact®, and ROZEREM® are registered trademarks of Takeda Pharmaceutical Company Limited and used under license by Takeda Pharmaceuticals America, Inc.

AMITIZA® is a registered trademark of Sucampo Pharmaceuticals, Inc.

KAPIDEX™ is a trademark of Takeda Pharmaceuticals North America, Inc. and used under license by Takeda Pharmaceuticals America, Inc.

PREVACID® is a registered trademark of Takeda Pharmaceuticals North America, Inc. and used under license by Takeda Pharmaceuticals America, Inc.

ULORIC® is a registered trademark of Teijin Pharma Limited and used under license by Takeda Pharmaceuticals America, Inc.

Please click here to view Takeda’s authorized wholesalers and distributors.





Page Top